Skip to main content

R. Daniel Beauchamp, M.D., F.A.C.S.

  • Deputy Director, Vanderbilt-Ingram Cancer Center
  • Co-Leader, Gastrointestinal Cancer Research Program
  • John Clinton Foshee Distinguished Professor of Surgery (Surgical Oncology)
  • Chair, Section of Surgical Sciences
  • Surgeon-in-Chief, Vanderbilt University Hospital

Phone

615-322-2363

Email

daniel.beauchamp@Vanderbilt.Edu
Vanderbilt University Medical Center
D-4316 Medical Center North
Nashville, TN 37232-2729

R. Daniel Beauchamp, M.D., F.A.C.S.

  • Deputy Director, Vanderbilt-Ingram Cancer Center
  • Co-Leader, Gastrointestinal Cancer Research Program
  • John Clinton Foshee Distinguished Professor of Surgery (Surgical Oncology)
  • Chair, Section of Surgical Sciences
  • Surgeon-in-Chief, Vanderbilt University Hospital

615-322-2363

daniel.beauchamp@Vanderbilt.Edu

Vanderbilt University Medical Center
D-4316 Medical Center North
Nashville, TN 37232-2729

Profile

Dr. Beauchamp is the John Clinton Foshee Distinguished Professor of Surgery, Chairman of the Section of Surgical Sciences, and Surgeon-in-Chief of Vanderbilt University Hospital and has held these positions since July 2001 and on the faculty at Vanderbilt since December 1994. His clinical practice encompassed Surgical Oncology including GI cancers, melanoma, sarcomas and breast cancer for almost 20 years, but is currently focused on breast cancer.

Dr. Beauchamp holds joint appointments as Professor in the Departments of Cell and Developmental Biology and Cancer Biology. He also serves as Deputy Director of the Vanderbilt-Ingram Cancer Center and now as co-leader of the GI Cancer Program. Dr. Beauchamp has two active R01 grants from NIH, and co-leads one of the main projects in the GI Cancer SPORE. His primary area of research interest has been in colorectal carcinogenesis, the biology of cancer cell invasion and metastasis, and in the identification of novel molecular biomarkers and therapeutic targets in colorectal and other alimentary tract malignancies. His work applies genomic, transcriptomic and proteomic technology to identify novel biomarkers and therapeutic targets in colorectal cancer. He also uses molecular genetics, chemical biology and cell biological approaches to examine mechanistic questions in cancer biology in both cell culture and mouse models. They have also developed a chemical biology project and have identified probes that inhibit Epithelial-to-Mesenchymal transition and restore E-cadherin expression in cells in which E-cadherin transcription is repressed. In addition to the basic cancer research, Dr. Beauchamp works in collaboration with his Medical Oncology and Radiation Oncology colleagues to accrue cancer patients to approved cancer clinical trials. He has trained and mentored numerous junior faculty members, physician scientist fellows, medical students, graduate students and post-doctoral fellows in his laboratory.

Education

  • M.D., The University of Texas Medical Branch, Galveston, Texas (1982)
  • B.S., Texas Tech University, Lubbock, Texas, (1978)

Research Emphasis

Transforming growth factor, Gastrointestinal carcinogenesis, Ras oncogene, colon cancer, epithelial to mesenchymal transition, metastasis, mouse models

Research Description

R. Daniel Beauchamp, MD, is the John Clinton Foshee Distinguished Professor of Surgery, Chairman of the Section of Surgical Sciences, and Surgeon-in-Chief of Vanderbilt University Hospital and has held these positions since July 2001 and on the faculty at Vanderbilt since December 1994. He holds joint appointments as professor in the departments of Cell and Developmental Biology and Cancer Biology. He also serves as Deputy Director of the Vanderbilt-Ingram Cancer Center. Dr. Beauchamp has two active R01 grants from NIH, and leads one of the main projects in the GI Cancer SPORE. Dr. Beauchamp's primary area of research interest has been in colorectal carcinogenesis, the biology of cancer cell invasion and metastasis, and in the identification of novel molecular biomarkers and therapeutic targets in colorectal and other alimentary tract malignancies. His work applies DNA microarray and proteomic technology to identify novel biomarkers and therapeutic targets in human colorectal cancer samples. He also uses molecular genetics, chemical biology and cell biological approaches to examine mechanistic questions in cancer biology in both cell culture and mouse models. In addition to the basic cancer research Dr. Beauchamp works in collaboration with his Medical Oncology and Radiation Oncology colleagues to accrue cancer patients to approved clinical trials. He has trained and mentored numerous junior faculty members, physician scientist fellows, medical students, graduate students and post-doctoral fellows in his laboratory. He is one of the few surgeon members of the ASCI.

Publications

Have any questions? Contact Us 1-877-936-8422 for more information